Literature DB >> 18420103

Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

Gijs M J M Welten1, Olaf Schouten, Sanne E Hoeks, Michel Chonchol, Radosav Vidakovic, Ron T van Domburg, Jeroen J Bax, Marc R H M van Sambeek, Don Poldermans.   

Abstract

OBJECTIVES: This study was designed to compare the long-term outcomes of patients with peripheral arterial disease (PAD) with a risk factor matched population of coronary artery disease (CAD) patients, but without PAD.
BACKGROUND: The PAD is considered to be a risk factor for adverse late outcome.
METHODS: A total of 2,730 PAD patients undergoing vascular surgery were categorized into groups: 1) carotid endarterectomy (n = 560); 2) elective abdominal aortic surgery (AAA) (n = 923); 3) acute AAA surgery (r-AAA) (n = 200), and 4) lower limb reconstruction procedures (n = 1,047). All patients were matched using the propensity score, with 2,730 CAD patients who underwent coronary angioplasty. Survival status of all patients was obtained. In addition, the cause of death and complications after surgery in PAD patients were noted. The Kaplan-Meier method was used to compare survival between the matched PAD and CAD population and the different operation groups. Prognostic risk factors and perioperative complications were identified with the Cox proportional hazards regression model.
RESULTS: The PAD patients had a worse long-term prognosis (hazard ratio 2.40, 95% confidence interval 2.18 to 2.65) and received less medication (beta-blockers, statins, angiotensin-converting enzyme inhibitors, aspirin, nitrates, and calcium antagonists) than CAD patients did (p < 0.001). Cerebro-cardiovascular complications were the major cause of long-term death (46%). Importantly, no significant difference in long-term survival was observed between the AAA and lower limb reconstruction groups (log rank p = 0.70). After vascular surgery, perioperative cardiac complications were associated with long-term cardiac death, and noncardiac complications were associated with all-cause death.
CONCLUSIONS: Long-term prognosis of vascular surgery patients is significantly worse than for patients with CAD. The vascular surgery patients receive less cardiac medication than CAD patients do, and cerebro-cardiovascular events are the major cause of late death.

Entities:  

Mesh:

Year:  2008        PMID: 18420103     DOI: 10.1016/j.jacc.2007.11.077

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  41 in total

1.  One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  Kim G Smolderen; Alan Bell; Yang Lei; Eric A Cohen; P Gabriel Steg; Deepak L Bhatt; Elizabeth M Mahoney
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

2.  Peripheral arterial disease in women: the effect of gender on diagnosis and treatment.

Authors:  Eduardo A Hernandez-Vila
Journal:  Tex Heart Inst J       Date:  2011

3.  Percutaneous transluminal angioplasty for peripheral artery disease confers cardiorenal protection.

Authors:  K Eguchi; A Murakami; T Horaguchi; M Kato; H Miyashita; K Kario
Journal:  J Hum Hypertens       Date:  2013-05-02       Impact factor: 3.012

Review 4.  Prevention and Management of Urgent/Emergent Limb Ischemia.

Authors:  Graham R McClure; Noel Chan; Eric Kaplovitch; Vinai Bhagirath; Sonia S Anand
Journal:  Curr Cardiol Rep       Date:  2021-03-11       Impact factor: 2.931

5.  Long-Term Outcomes and Causes of Death in Patients With Renovascular Disease Undergoing Renal Artery Stenting.

Authors:  Eric L Wallace; Ediz Tasan; Bryon S Cook; Richard Charnigo; Ahmed K Abdel-Latif; Khaled M Ziada
Journal:  Angiology       Date:  2015-09-30       Impact factor: 3.619

6.  Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

Authors:  Anthony A Bavry; R David Anderson; Yan Gong; Scott J Denardo; Rhonda M Cooper-Dehoff; Eileen M Handberg; Carl J Pepine
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

7.  Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.

Authors:  S Marlene Grenon; Eric Vittinghoff; Christopher D Owens; Michael S Conte; Mary Whooley; Beth E Cohen
Journal:  Vasc Med       Date:  2013-07-08       Impact factor: 3.239

8.  Two decades of progress in vascular medicine.

Authors:  Nicholas J Leeper; Jason T Lee; John P Cooke
Journal:  Am J Med       Date:  2011-06-16       Impact factor: 4.965

9.  Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Bruce E Landon; A James O'Malley; Philip P Goodney; Randall R DeMartino; Shipra Arya; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-08-27       Impact factor: 4.268

10.  Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery.

Authors:  Willem-Jan Flu; Sanne E Hoeks; Jan-Peter van Kuijk; Jeroen J Bax; Don Poldermans
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.